Literature DB >> 2110975

Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary smooth muscle cells.

S J Chung1, H L Fung.   

Abstract

The vasodilating action of nitroglycerin (NTG) is thought to be mediated by its metabolic activation to nitric oxide (NO) in the vascular smooth muscle cell, but the site at which this process occurs has not been defined. To determine which cellular component is primarily responsible for this metabolic activation, subcellular fractions of bovine vascular smooth muscle cells were prepared and incubated with NTG along with cofactors. Time-dependent headspace NO concentrations generated in these preparations were determined directly by chemiluminescence detection. A mathematical model was developed to relate headspace NO with the NO-generating activity in each incubation, correcting for the concurrent processes of NO partitioning between the headspace and the incubation medium, and NO degradation in these two phases. The estimated NO-generating activities from different subcellular fractions were well correlated with the activities of two enzyme markers of the plasma membrane (K(+)-activated ouabain sensitive p-nitrophenyl phosphatase and 5'-nucleotidase), but not with those of the mitochondria, endoplasmic reticulum or the cytosol. These results indicate that the enzyme(s) responsible for the metabolic activation of NTG, and possibly other organic nitrate vasodilators, are associated with the plasma membrane in bovine coronary smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2110975

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  25 in total

Review 1.  Nitrates and nitrites in the treatment of ischemic cardiac disease.

Authors:  Vaughn E Nossaman; Bobby D Nossaman; Philip J Kadowitz
Journal:  Cardiol Rev       Date:  2010 Jul-Aug       Impact factor: 2.644

2.  Reduced vascular reactivity after chronic nitroglycerine administration: EDHF mechanism is also downregulated.

Authors:  Pierre-Yves von der Weid; Harold A Coleman
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

3.  Nitroxergic nerves mediate vagally induced relaxation in the isolated stomach of the guinea pig.

Authors:  K M Desai; A Zembowicz; W C Sessa; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

Review 4.  Novel therapies for cyclic GMP control of vascular smooth muscle growth.

Authors:  David A Tulis
Journal:  Am J Ther       Date:  2008 Nov-Dec       Impact factor: 2.688

5.  Impaired vasodilator response to organic nitrates in isolated basilar arteries.

Authors:  D Martens; G Kojda
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

6.  Role of L-arginine in the vascular actions and development of tolerance to nitroglycerin.

Authors:  G Abou-Mohamed; W H Kaesemeyer; R B Caldwell; R W Caldwell
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 7.  Mechanisms of action of nitrates.

Authors:  K E Torfgård; J Ahlner
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

8.  Vascular and anti-platelet actions of 1,2- and 1,3-glyceryl dinitrate.

Authors:  D Salvemini; A Pistelli; E Anggard
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

9.  Cardiovascular actions of the furoxan CAS 1609, a novel nitric oxide donor.

Authors:  H Bohn; J Brendel; P A Martorana; K Schönafinger
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

10.  Release of nitric oxide from glyceryl trinitrate by captopril but not enalaprilat: in vitro and in vivo studies.

Authors:  D Salvemini; A Pistelli; V Mollace
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.